Hwabao WP CSI Medical Service ETF(512170) Falls 1.54%, Sees Net Inflow of 487 Million Yuan for Six Consecutive Days

NewTimeSpace News, as of 14:13 on May 20, 2026, Hwabao Medical ETF (512170) fell 1.54%, with its latest quoted price at 0.32 yuan. (The stocks listed above are merely index constituents and do not constitute any specific recommendation.)

In terms of liquidity, Hwabao Medical ETF recorded an intraday turnover rate of 1.48%, with a trading volume of 427 million yuan. Over a longer horizon, as of May 19, the ETF's average daily turnover over the past year stood at 638 million yuan, ranking first among comparable funds.

Regarding scale, Hwabao Medical ETF's AUM increased by 1.309 billion yuan over the past six months, achieving significant growth, with the new scale increment ranking 1/4 among comparable funds. (Data source: Wind)

In terms of share size, Hwabao Medical ETF's share count increased by 1.196 billion units over the past week, achieving significant growth, with the new share increment ranking 1/4 among comparable funds. (Data source: Wind)

From a net capital inflow perspective, Hwabao Medical ETF experienced continuous net inflows for six consecutive days, with the highest single-day net inflow of 222 million yuan, totaling an inflow of 487 million yuan, and an average daily net inflow of 81.1680 million yuan. (Data source: Wind)

Data shows that leveraged funds continue to position themselves. The net margin purchase amount for Hwabao Medical ETF month-to-date reached 8.6156 million yuan, and the latest margin balance stood at 1.196 billion yuan. (Data source: Wind)

As of May 19, Hwabao Medical ETF's net value increased by 0.87% over the past year. In terms of return capability, as of May 19, 2026, since its inception, the ETF achieved a highest single-month return of 29.81%, a longest consecutive gaining streak of six months with a cumulative gain of 26.58%, and an average return of 6.68% during up months. As of May 19, 2026, since its inception, the ETF's annualized excess return over its benchmark was 1.64%.

In terms of drawdown, as of May 19, 2026, Hwabao Medical ETF's relative drawdown versus its benchmark since the beginning of the year was 0.18%.

In terms of fees, Hwabao Medical ETF has a management fee rate of 0.50% and a custody fee rate of 0.10%.

In terms of tracking accuracy, as of May 19, 2026, Hwabao Medical ETF's one-month tracking error was 0.016%, the highest tracking precision among comparable funds.

From a valuation perspective, the latest price-to-earnings ratio (PE-TTM) of the CSI Medical Index, which Hwabao Medical ETF tracks, is only 28.38 times, placing it at the 1.95th percentile over the past year—meaning the valuation is lower than that of over 98.05% of the time in the past year, indicating a historically low level.

Hwabao Medical ETF closely tracks the CSI Medical Index. The CSI Medical Index selects securities of listed companies in the healthcare and pharmaceutical industry whose businesses involve medical themes such as medical devices, medical services, and medical information technology as index constituents, in order to reflect the overall performance of listed company securities in the medical theme.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.